Interventions for valvular disease
Thirty-day outcomes of a novel transcatheter heart valve to treat degenerated surgical valves: the VIVALL multicentre, single-arm, pilot study October 4, 2019 | 10.4244/EIJ-D-19-00331
Showing 1-6 of 6 articles
Coronary interventions
Impact of target lesion location on procedural and angiographic outcomes of rotational atherectomy versus modified balloon angioplasty prior to drug-eluting stent implantation in severely calcified coronary lesions:a subgroup analysis of the PREPARE-CALC randomized trial October 1, 2019 | 10.4244/EIJ-D-19-00488
Interventions for valvular disease
Thirty-day outcomes of a novel transcatheter heart valve to treat degenerated surgical valves - The “VIVALL” multi-center, single-arm, pilot study July 30, 2019 | 10.4244/EIJ-D-19-00331
Interventions for valvular disease
Long-term durability and haemodynamic performance of a self-expanding transcatheter heart valve beyond five years after implantation: a prospective observational study applying the standardised definitions of structural deterioration and valve failure July 20, 2018 | 10.4244/EIJ-D-18-00041
Interventions for valvular disease
Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation January 20, 2017 | 10.4244/EIJ-D-15-00412
Interventions for valvular disease
Redo TAVI: initial experience at two German centres September 18, 2016 | 10.4244/EIJV12I7A144
